A uniform pricing regime ignores the heterogeneity within the pharma sector
Dr Amit Kumar: How can policy frameworks better align commercial interests in the pharma sector with broader public health goals?…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Interviews
India brings together a rare and powerful combination of capabilities
Dr Kshitij Panse,Chief Operation Officer,GATINN by Servier,in an interaction with Kalyani Sharma, discusses the strategic…
Mumbai Experience Center reflects Agilent’s continued commitment to India
Bharat Bhardwaj, Vice President, Asia Pacific, Agilent Technologies spoke to Viveka Roychowdhury on why Agilent has been…
Industrial and infrastructure sectors are undergoing rapid modernisation
How critical is infrastructure automation in pharma facilities?
Infrastructure is integral to maintaining controlled…
Companies need to look at anti-counterfeiting solutions from the perspective of protecting revenue,…
Can you briefly explain ASPA’s evolution and how the anti‑counterfeiting ecosystem has changed?
ASPA as an organisation started…
What truly differentiates Transchem is our technical-first approach
What are Transchem's core focus areas today, and which segments are driving your growth?
Transchem’s core focus today is on…
Targeted incentives for innovation-driven research would further strengthen India’s biotech…
What unmet need are you fundamentally solving?
Vyome is focused on areas of significant unmet medical need within…
In 2026, India serves as the reliable ‘technical engine’ for global research
How would you describe the current and evolving clinical research landscape in India, and what key shifts are shaping its future?…
Our approach is to combine localised production with global quality standards
What do you see as India’s role in the evolving global life sciences and biopharma value chain over the next decade?
India is…
India has the infrastructure to lead the global gene therapy market
AI is often described as a game changer in drug discovery and manufacturing. Where do you see it making the biggest difference…
BMS is committed to pioneering AI-driven innovation in pharma commercialisation
AI is reshaping pharma commercialisation, transforming how companies engage healthcare professionals and deliver scientific…
Automation, digitalisation, and integrated workflows are redefining India’s life sciences landscape
Nandakumar Kalathil, Country General Manager – India, Agilent Technologies, shares insights into Agilent’s performance, strategic…
Quick-commerce players are rapidly gaining share in acute, event-based medicines
Quick commerce is reshaping pharma distribution. But the real transformation is happening deeper in the supply chain. Uday Kadam,…
Rx-to-OTC is not a channel shift—it’s a complete business model shift
By 2030, what will truly differentiate winning OTC players in India from the rest?
By 2030, the biggest differentiator for…
Good pharma-focused developers are now co-designing with GMP/WHO/USFDA consultants from day zero
How have pharma companies changed the way they plan and choose real estate after the pandemic? What matters most to them now,…
Local focus to strengthen Indian pharmaceutical manufacturers
Why is localising format part production an important step for Indian pharmaceutical companies and Romaco?
Sanjeev Nimkar: It…
India at a jumping-off point in terms of commitment to global clinical studies
If you were to pick one or two trends in clinical trials and research in India in 2026, what would you be looking at? What are the…
Speed and flexibility play a critical role in how we compete with larger global players
As a young leader stepping into a global business, how do you envision the next phase of growth for Shriji Polymers?
As a young…
Our goal is to help companies reduce cost per cubic meter of wastewater treatment
The pharma industry is considered one of the most polluting industries, not just in India, but across the world. Antibiotics have…
We train professionals to see quality not as a checklist but as a mindset
How does IGMPI’s training ecosystem directly address the root causes of patient safety lapses such as weak documentation,…